An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration date
Evaluation and Treatment of Primary Central Nervous System Lymphoma 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Amyloidosis: Diagnosis, Treatment, and Supportive Care 0.50 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
Optimizing the Use of Bispecific Antibodies in Hematologic Malignancies 1.00 12/01/2024 - 12:00am to 12/01/2025 - 12:00am
NCCN Guidelines® Insights - Survivorship, Version 2.2024 1.00 12/10/2024 - 12:00am to 12/10/2025 - 12:00am
Unraveling Cancer Pain Dynamics 1.00 12/16/2024 - 12:00am to 10/31/2025 - 11:59pm
Patient Management Simulator: Treatment Recommendations for Kidney Cancer with Management of Immunotherapy-Related Toxicities 12/19/2024 - 12:00am to 12/19/2025 - 12:00am
Vital Questions for Treatment of Bladder Cancer: Expert Insights on Recent and Near-Future Changes 1.00 12/20/2024 - 12:00am to 12/20/2025 - 12:00am
An Interactive Case-Based Review of Chronic Lymphocytic Leukemia: Experts Explore the Latest Evidence and Guideline Updates 2.00 12/20/2024 - 12:00am to 12/20/2025 - 12:00am
Recorded Presentation from the NCCN Pharmacy Updates: Advances in Neoadjuvant Treatment Options in Locally Advanced and Metastatic Rectal Cancer with... 1.00 12/20/2024 - 12:00am to 12/20/2025 - 12:00am
NCCN Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology 01/07/2025 - 12:00am to 12/31/2025 - 12:00am
NCCN Guidelines® Insights - Lung Cancer Screening, Version 1.2025 1.00 01/10/2025 - 12:00am to 01/10/2026 - 12:00am
Archived NCCN Tumor Boards: Treatment Selection Strategies and Barriers to Clinical Care in Metastatic Breast Cancer 1.00 01/21/2025 - 12:00am to 01/21/2026 - 12:00am
Are You Applying the Latest Guidelines for Multiple Myeloma? Experts Discuss Equitable, Evidence-Based Care 1.50 01/31/2025 - 12:00am to 01/31/2026 - 12:00am
NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma 1.00 02/04/2025 - 12:00am to 08/10/2025 - 12:00am

Pages